Nephros(NEPH)

2.19 0.00 0.0%

今开:2.19昨收:2.19
最高:2.19 最低:2.19
涨停价:0.0跌停价:0.0
总市值:2.3091664E7

Nephros的热门讨论

持股变动声明

Nephros(NEPH)03-15 04:35

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011  Size: 6 KB 网页链接查看全文

股东委托书协议

Nephros(NEPH)04-13 04:05

$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Nephros(NEPH)03-15 04:45

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012  Size: 12 KB 网页链接查看全文

年度财报

Nephros(NEPH)03-16 04:35

$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107  Act: 34  Size: 7 MB 网页链接查看全文

当期报告

Nephros(NEPH)03-08 05:25

$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009216  Act: 34  Size: 345 KB 网页链接查看全文

其他

Nephros(NEPH)04-13 04:15

$Nephros(NEPH)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-014448  Act: 34  Size: 1 MB 网页链接查看全文

其他

Nephros(NEPH)04-13 04:15

$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447  Act: 34  Size: 709 KB 网页链接查看全文

Nephros的最新讨论

TOPVIEW |2021.7.8 Bio-market主要涨跌一览

蹊之美股生物医药2021-07-09 20:55

作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers: 
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文

Nephros的公告

当期报告

$Nephros(NEPH)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-22-001104  Act: 34  Size: 285 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028832  Size: 16 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028833  Size: 7 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028834  Size: 11 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028835  Size: 10 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028836  Size: 10 KB 网页链接

当期报告

$Nephros(NEPH)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001493152-21-030449  Act: 34  Size: 213 KB 网页链接

季度财报

$Nephros(NEPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-21-027249  Act: 34  Size: 6 MB 网页链接

当期报告

$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-025001  Act: 34  Size: 238 KB 网页链接

招股说明书

$Nephros(NEPH)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-21-022776  Act: 33  Size: 190 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20